1. Home
  2. TELA vs PAI Comparison

TELA vs PAI Comparison

Compare TELA & PAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TELA
  • PAI
  • Stock Information
  • Founded
  • TELA 2012
  • PAI 1973
  • Country
  • TELA United States
  • PAI United States
  • Employees
  • TELA N/A
  • PAI N/A
  • Industry
  • TELA Medical/Dental Instruments
  • PAI Trusts Except Educational Religious and Charitable
  • Sector
  • TELA Health Care
  • PAI Finance
  • Exchange
  • TELA Nasdaq
  • PAI Nasdaq
  • Market Cap
  • TELA 104.0M
  • PAI 117.4M
  • IPO Year
  • TELA 2019
  • PAI N/A
  • Fundamental
  • Price
  • TELA $2.72
  • PAI $12.70
  • Analyst Decision
  • TELA Strong Buy
  • PAI
  • Analyst Count
  • TELA 4
  • PAI 0
  • Target Price
  • TELA $9.25
  • PAI N/A
  • AVG Volume (30 Days)
  • TELA 186.3K
  • PAI 25.0K
  • Earning Date
  • TELA 03-20-2025
  • PAI 01-01-0001
  • Dividend Yield
  • TELA N/A
  • PAI 4.78%
  • EPS Growth
  • TELA N/A
  • PAI N/A
  • EPS
  • TELA N/A
  • PAI N/A
  • Revenue
  • TELA $68,649,000.00
  • PAI N/A
  • Revenue This Year
  • TELA $30.39
  • PAI N/A
  • Revenue Next Year
  • TELA $25.51
  • PAI N/A
  • P/E Ratio
  • TELA N/A
  • PAI N/A
  • Revenue Growth
  • TELA 29.34
  • PAI N/A
  • 52 Week Low
  • TELA $2.30
  • PAI $10.59
  • 52 Week High
  • TELA $7.18
  • PAI $12.63
  • Technical
  • Relative Strength Index (RSI)
  • TELA 50.00
  • PAI 59.00
  • Support Level
  • TELA $2.53
  • PAI $12.45
  • Resistance Level
  • TELA $2.96
  • PAI $12.80
  • Average True Range (ATR)
  • TELA 0.13
  • PAI 0.18
  • MACD
  • TELA 0.02
  • PAI 0.00
  • Stochastic Oscillator
  • TELA 44.19
  • PAI 55.56

About TELA TELA Bio Inc.

TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.

About PAI Western Asset Investment Grade Income Fund Inc.

Western Asset Investment Grade Income Fund Inc is a closed-end diversified investment company. The company designed primarily as a long-term investment and not as a trading vehicle. The fund seeks a high level of current income, consistent with prudent investment risk, through investment in a diversified portfolio of debt securities. Its portfolio is invested in securities which may be convertible into or exchangeable for, or carry warrants to purchase, common stock or other equity interests; and preferred stock.

Share on Social Networks: